Published in J Virol on May 01, 1979
Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens. J Virol (1980) 7.51
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1985) 5.42
Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol (1980) 4.88
Monoclonal antibodies against simian virus 40 nuclear large T tumour antigen: epitope mapping, papova virus cross-reaction and cell surface staining. EMBO J (1984) 2.08
Acylated simian virus 40 large T-antigen: a new subclass associated with a detergent-resistant lamina of the plasma membrane. EMBO J (1983) 1.55
SV40 T antigen and the exocytotic pathway. EMBO J (1985) 1.52
A charged amino acid substitution within the transmembrane anchor of the Rous sarcoma virus envelope glycoprotein affects surface expression but not intracellular transport. J Cell Biol (1987) 1.50
Simian virus 40 T-antigen-related cell surface antigen: serological demonstration on simian virus 40-transformed monolayer cells in situ. J Virol (1980) 1.36
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30
Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen. J Virol (1980) 1.26
A second domain of simian virus 40 T antigen in which mutations can alter the cellular localization of the antigen. Mol Cell Biol (1986) 1.25
Construction and characterization of viable deletion mutants of simian virus 40 lacking sequences near the 3' end of the early region. J Virol (1982) 1.23
Nonlytic simian virus 40-specific 100K phosphoprotein is associated with anchorage-independent growth in simian virus 40-transformed and revertant mouse cell lines. Mol Cell Biol (1981) 1.22
Identification and initial characterization of a new low-molecular-weight virus-encoded T antigen in a line of simian virus 40-transformed cells. J Virol (1980) 1.11
Simian virus 40 T-antigen: identification of tryptic peptides in the C-terminal region and definition of the reading frame. J Virol (1980) 1.05
Antigenic structure of simian virus 40 large tumor antigen and association with cellular protein p53 on the surfaces of simian virus 40-infected and -transformed cells. J Virol (1984) 1.04
The kinase activity of SV40 large T antigen is mediated by a cellular kinase. EMBO J (1986) 1.01
Membrane interactions of simian virus 40 large T-antigen: influence of protein sequences and fatty acid acylation. Mol Cell Biol (1984) 1.00
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
Fine mapping two distinct antigenic sites on simian virus 40 (SV40) T antigen reactive with SV40-specific cytotoxic T-cell clones by using SV40 deletion mutants. J Virol (1988) 0.98
Subcellular localisation of the middle and large T-antigens of polyoma virus. EMBO J (1986) 0.97
Association of simian virus 40 T antigen with the nuclear matrix of infected and transformed monkey cells. Mol Cell Biol (1984) 0.96
Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodies. J Exp Med (1986) 0.96
Association of a major transcriptional regulatory protein, ICP4, of herpes simplex virus type 1 with the plasma membrane of virus-infected cells. J Virol (1991) 0.92
Surface T-antigen expression in simian virus 40-transformed mouse cells: correlation with cell growth rate. Mol Cell Biol (1985) 0.91
Possible role of anti-idiotypic antibodies in the induction of tumor immunity. J Clin Invest (1987) 0.91
Evidence for transmembrane orientation of acylated simian virus 40 large T antigen. J Virol (1985) 0.88
The myc proteins are not associated with chromatin in mitotic cells. EMBO J (1984) 0.87
Plasma membrane orientation of simian virus 40 T antigen in three transformed cell lines mapped with monoclonal antibodies. J Virol (1985) 0.87
Dynamic nature of the association of large tumor antigen and p53 cellular protein with the surfaces of simian virus 40-transformed cells. J Virol (1984) 0.86
Interaction and co-localization of JC virus large T antigen and the F-box protein β-transducin-repeat containing protein. Virology (2010) 0.85
Membrane 126-kilodalton phosphoglycoprotein associated with human carcinomas identified by a hybridoma antibody to mammary carcinoma cells. Proc Natl Acad Sci U S A (1983) 0.84
A subclass of polyomavirus middle tumor antigen binds to DNA cellulose. J Virol (1986) 0.82
The cellular secretory pathway is not utilized for biosynthesis, modification, or intracellular transport of the simian virus 40 large tumor antigen. J Virol (1987) 0.81
Transformation of precrisis human cells by the simian virus 40 cytoplasmic-localization mutant pSVCT3 is accompanied by nuclear T antigen. J Virol (1987) 0.80
Cell surface T antigen in cells infected with simian virus 40 or an adenovirus-simian virus 40 hybrid, Ad2+D2. J Virol (1981) 0.80
Absence of a structural basis for intracellular recognition and differential localization of nuclear and plasma membrane-associated forms of simian virus 40 large tumor antigen. Mol Cell Biol (1986) 0.79
Fluctuation of simian virus 40 (SV40) super T-antigen expression in tumors induced by SV40-transformed mouse mammary epithelial cells. J Virol (1986) 0.79
Only a minor fraction of plasma membrane-associated large T antigen in simian virus 40-transformed mouse tumor cells (mKSA) is exposed on the cell surface. J Virol (1989) 0.79
Induction of cellular DNA synthesis by a simian virus 40 mutant defective in nuclear transport of T antigen. Mol Cell Biol (1985) 0.78
Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells. Clin Exp Immunol (1993) 0.77
Initial characterization of the membrane-associated form of ICP4 of herpes simplex virus type 1. J Virol (1995) 0.77
Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes. Clin Exp Immunol (1994) 0.77
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci (1964) 127.96
Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol (1975) 47.77
DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY. Ann N Y Acad Sci (1964) 26.94
Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence. Virology (1962) 24.93
Identification of a transformation-specific antigen induced by an avian sarcoma virus. Nature (1977) 16.32
A SPECIFIC COMPLEMENT-FIXING ANTIGEN PRESENT IN SV40 TUMOR AND TRANSFORMED CELLS. Proc Natl Acad Sci U S A (1963) 10.72
Regulation of tumor antigen synthesis by simain virus 40 gene A. J Virol (1975) 9.93
Organization and expression of early genes of simian virus 40. Proc Natl Acad Sci U S A (1978) 7.10
Role of simian virus 40 gene A function in maintenance of transformation. J Virol (1975) 6.63
Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells. Virology (1975) 5.47
Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells. Cell (1978) 5.23
Identification of simian virus 40 protein A. J Virol (1977) 4.93
Specificity of resistance to tumor challenge of polyoma and SV 40 virus-immune hamsters. Proc Soc Exp Biol Med (1963) 4.31
Specificity of virus-induced resistance to transplantation of polyoma and SV 40 tumors in adult hamsters. Proc Soc Exp Biol Med (1963) 4.23
Effect of SV 40 virus immunization on growth of transplantable SV 40 and polyoma virus tumors in hamsters. Proc Soc Exp Biol Med (1963) 4.19
Modification of simian virus 40 protein A. J Virol (1977) 3.79
Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus. Proc Natl Acad Sci U S A (1977) 3.68
Tumorigencity of simian papovavirus SV40 and of virus-transformed cells. J Natl Cancer Inst (1963) 3.23
Effect of cell chromosome number on simian virus 40 replication. Exp Cell Res (1973) 3.20
VIRUS-INDUCED INTRANUCLEAR ANTIGEN IN CELLS TRANSFORMED BY PAPOVAVIRUS SV40. Proc Soc Exp Biol Med (1965) 2.95
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. V. Isolation of additional hybrids which differ in their simian virus 40-specific biological properties. J Virol (1973) 2.87
PAPOVAVIRUS SV40: FAILURE TO ISOLATE INFECTIOUS VIRUS FROM TRANSFORMED HAMSTER CELLS SYNTHESIZING SV40-INDUCED ANTIGENS. Virology (1964) 2.60
Transformation of BALB/c-3T3 cells by tsA mutants of simian virus 40: temperature sensitivity of the transformed phenotype and retransofrmation by wild-type virus. J Virol (1978) 2.42
IMMUNITY IN HAMSTERS TO CELLS TRANSFORMED IN VITRO AND IN VIVO BY SV40. TESTS FOR ANTIGENIC RELATIONSHIP AMONG THE PAPOVAVIRUSES. J Immunol (1963) 2.11
Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res (1972) 1.73
NEW SURFACE ANTIGEN IN CELLS TRANSFORMED BY SIMIAN PAPOVAVIRUS SV40. Proc Soc Exp Biol Med (1965) 1.73
Prevention of SV40 virus oncogenesis in hamsters. I. Tumor resistance induced by human cells transformed by SV40. Proc Natl Acad Sci U S A (1965) 1.70
Cellular and cell-free synthesis of simian virus 40 T-antigens in permissive and transformed cells. J Virol (1978) 1.66
Studies of nondefective Adenovirus 2-Simian virus 40 hybrid viruses. 8. Association of Simian virus 40 transplantation antigen with a specific region of the early viral genome. J Virol (1973) 1.42
Antigenic distinctions of glycoproteins in plasma and mitochondrial membranes of lymphoid cells neoplastically transformed by simian virus 40. Proc Natl Acad Sci U S A (1977) 1.41
Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells. J Natl Cancer Inst (1973) 1.38
Nuclear preparations of SV40-transformed cells contain tumor-specific transplantation antigen activity. Virology (1977) 1.37
Resting state in normal and simian virus 40 transformed Chinese hamster lung cells. Proc Natl Acad Sci U S A (1976) 1.33
Induction of SV40 transplantation antigen (TrAg) during the lytic cycle. Virology (1970) 1.33
Detergent solubilization and partial purification of tumor specific surface and transplantation antigens from SV40-virus-transformed mouse cells. Int J Cancer (1977) 1.25
Simian virus 40 tumor-specific proteins: subcellular distribution and metabolic stability in HeLa cells infected with nondefective adenovirus type 2-simian virus 40 hybrid viruses. J Virol (1977) 1.22
Expression and thermal stability of simian virus 40 tumor-specific transplantation antigen and tumor antigen in wild type- and tsA mutant-transformed cells. J Virol (1977) 1.15
Purification of simian virus 40 tumor antigen from a line of simian virus 40-transformed human cells. Proc Natl Acad Sci U S A (1977) 1.14
Simian virus 40-specific polypeptides in AD2+ ND1- and Ad2+ ND4-infected cells. J Virol (1976) 1.13
Membranes of normal hamster lymphocytes and lymphoid cells neoplastically transformed by simian virus 40. II. Plasma membrane proteins analyzed by dodecyl sulfate-polyacrylamide gel electrophoresis and two-dimensional immune electrophoresis. J Natl Cancer Inst (1976) 1.12
Membranes of normal hamster lymphocytes and lymphoid cells neoplastically transformed by simian virus 40. I. High-yield purification of plasma membrane fragments. J Natl Cancer Inst (1976) 1.11
Role of the simian virus 40 gene A product in regulation of DNA synthesis in transformed cells. J Virol (1978) 1.06
Prevention and interruption of SV40 induced transplantation immunity with tumor cell extracts. Proc Soc Exp Biol Med (1966) 0.96
Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40. J Natl Cancer Inst (1974) 0.96
Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells. J Natl Cancer Inst (1977) 0.94
Characterization of simian cells tranformed by temperature-sensitive mutants of simian virus 40. J Virol (1976) 0.93
Transformation by simian virus 40 induces virus-specific, related antigens in the surface membrane and nuclear envelope. Proc Natl Acad Sci U S A (1977) 0.89
Tumor-specific transplantation antigen is expressed during SV40 lytic infection with wild-type and tsA mutant viruses. Virology (1977) 0.87
Biology of SV40 transplantation antigen (TrAg). I. Demonstration of SV40 TrAg on glutaraldehyde-fixed SV40-infected African green monkey kidney cells. Virology (1976) 0.87
Expression of tumor-specific transplantation antigen in cell lines transformed by wild-type of tsA mutant simian virus 40. J Virol (1977) 0.84
Induction of common transplantation antigen by various isolates of papovavirus SV40 and by virus rescued from transformed cells. Intervirology (1973) 0.82
Comparative behavior of simian virus 40 T-antigen and of tumor-specific surface and transplantation antigens during partial purification. Cancer Res (1978) 0.82
Biology of simian virus 40 (SV40) transplantation antigen (TrAg) III. Involvement of SV40 gene A in the expression of TrAg in permissive cells. Virology (1977) 0.81
Membrane proteins of cells neoplastically transformed by simian virus 40. Prog Exp Tumor Res (1978) 0.80
Comparative immunology of carcinogenesis by DNA viruses. Contemp Top Immunobiol (1977) 0.78
Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse. J Natl Cancer Inst (1977) 0.78
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
Role of simian virus 40 gene A function in maintenance of transformation. J Virol (1975) 6.63
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85
The effect of arabinofuranosylcytosine on the growth cycle of simian virus 40. Virology (1965) 2.98
Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci U S A (1984) 2.44
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28
SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene (2000) 2.03
Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Biochim Biophys Acta (1975) 1.95
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol (1995) 1.95
Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol (1990) 1.80
Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells. J Bacteriol (1966) 1.79
Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J Virol (1989) 1.76
Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res (1972) 1.73
Hepatitis B virus X protein interferes with cellular DNA repair. J Virol (1998) 1.62
Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog (1996) 1.56
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology (1995) 1.37
Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology (1993) 1.36
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30
Variation in properties of plaque progeny of PARA (defective simian papovavirus 40)-adenovirus 7. J Virol (1969) 1.28
The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol Cell Biol (1994) 1.27
Papovaviridae. Intervirology (1974) 1.26
Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen. J Virol (1980) 1.26
Ligand and cation binding are dual functions of a discrete segment of the integrin beta 3 subunit: cation displacement is involved in ligand binding. Cell (1994) 1.26
Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18. J Biol Chem (1994) 1.26
p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res (1992) 1.23
Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res (1991) 1.22
Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses. J Virol (1984) 1.21
Replication in simian cells of defective viruses in an SV40-adenovirus "hybrid" population. J Bacteriol (1966) 1.21
The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties. Biochim Biophys Acta (1986) 1.21
Variants of defective simian papovavirus 40 (PARA) characterized by cytoplasmic localization of simian papovavirus 40 tumor antigen. J Virol (1969) 1.21
Modification of simian virus 40 large tumor antigen by glycosylation. Virology (1985) 1.18
Demonstration of infectious deoxyribonucleic acid in transformed cells. I. Recovery of simian virus 40 from yielder and nonyielder transformed cells. J Virol (1972) 1.18
Intracellular transport of SV40 large tumor antigen: a mutation which abolishes migration to the nucleus does not prevent association with the cell surface. Virology (1982) 1.17
Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol (1998) 1.17
Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts. Mol Cell Biol (1986) 1.17
Studies with human papilloma virus modeled after known papovavirus systems. J Natl Cancer Inst (1972) 1.17
Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv Cancer Res (1995) 1.16
Complementation between a defective monkey cell-adapting component and human adenoviruses in simian cells. Virology (1967) 1.14
Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL x DBA/2f F1 mice. Cancer Res (1980) 1.14
Biochemical characterization of nuclear and cytoplasmic forms of SV40 tumor antigens encoded by parental and transport-detective mutant SV40-adenovirus 7 hybrid viruses. Virology (1980) 1.12
Association of SV40 large tumor antigen and cellular proteins on the surface of SV40-transformed mouse cells. Virology (1982) 1.11
Laryngeal papilloma: etiologic and therapeutic considerations. Ann Otol Rhinol Laryngol (1973) 1.08
Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol (1988) 1.07
Role of the simian virus 40 gene A product in regulation of DNA synthesis in transformed cells. J Virol (1978) 1.06
SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer (1997) 1.05
Identification of a conserved sequence in the non-coding regions of many human genes. Nucleic Acids Res (1989) 1.05
Detection of mouse mammary tumor virus RNA in BALB/c tumor cell lines of nonviral etiologies. J Virol (1978) 1.04
Antigenic structure of simian virus 40 large tumor antigen and association with cellular protein p53 on the surfaces of simian virus 40-infected and -transformed cells. J Virol (1984) 1.04
Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J Gen Virol (1997) 1.03
Transformation of primate and rodent cells by temperature-sensitive mutants of SV40. Cold Spring Harb Symp Quant Biol (1975) 1.03
Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J Neurovirol (1998) 1.01
Detection of simian virus 40 surface-associated large tumor antigen by enzyme-catalyzed radioiodination. Int J Cancer (1982) 1.01
Inactivation and density studies with PARA-adenovirus 7 (SV40-adenovirus "hybrid" population). J Immunol (1966) 1.00
Inhibition of nuclear migration of wild-type SV40 tumor antigen by a transport-defective mutant of SV40-adenovirus 7 hybrid virus. Virology (1980) 1.00
Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene. J Virol (1991) 1.00
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
Structural comparisons of wild-type and nuclear transport-defective simian virus 40 large tumor antigens. Virology (1984) 0.98
Construction of SV40 deletion mutants and delimitation of the binding domain for heat shock protein to the amino terminus of large T-antigen. Virus Res (1994) 0.97
The role of SV40 gene A in the alteration of microfilaments in transformed cells. Exp Cell Res (1977) 0.96
Hepatitis B virus and hepatocellular carcinoma. Prog Med Virol (1992) 0.95
Properties of transformed hamster cells containing SV40 tumor antigen in the cytoplasm. Int J Cancer (1971) 0.95
Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Cancer Res (1993) 0.95
Comparative analysis of casein synthesis during mammary cell differentiation in collagen and mammary gland development in vivo. Dev Biol (1985) 0.95
Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors. Semin Cancer Biol (2001) 0.95
Detection of a complex of SV40 large tumor antigen and 53K cellular protein on the surface of SV40-transformed mouse cells. J Cell Biochem (1982) 0.94
Apolipoprotein B gene regulatory factor-2 (BRF-2) is structurally and immunologically highly related to hepatitis B virus X associated protein-1 (XAP-1). Biochemistry (1997) 0.94
Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China. J Natl Cancer Inst (1987) 0.94
Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer (1994) 0.94
SV40 large T-antigen: dual oncogene. Cancer Surv (1986) 0.94
Molecular characterization of SV40 DNA in multiple samples from a human mesothelioma. Anticancer Res (2000) 0.94
Neutrophil inhibitory factor prevents neutrophil-dependent lung injury. J Immunol (1995) 0.94
Variation in properties of SV40-transformed simian cell lines detected by superinfection with SV40 and human adenoviruses. Virology (1971) 0.94
Comparison of ability of defective foreign genomes (PARA and MAC) carried by human adenoviruses to induce SV40 transplantation immunity. J Immunol (1967) 0.93
Transformation of mouse mammary epithelial cells by papovavirus SV40. Exp Mol Pathol (1984) 0.93
Characterization of simian cells tranformed by temperature-sensitive mutants of simian virus 40. J Virol (1976) 0.93
Polyomaviruses and human tumors: a brief review of current concepts and interpretations. Front Biosci (1999) 0.93
Differential expression of poly(A)-adjacent sequences of mammary tumor virus RNA in murine mammary cells. Proc Natl Acad Sci U S A (1978) 0.92
Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol Carcinog (1994) 0.92
Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. Dev Biol Stand (1998) 0.92
Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann Neurol (1995) 0.92
Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice. Cancer Res (1984) 0.92
Recent advances in molecular pathology. The state of the viral genome in cells transformed by simian virus 40: a review. Exp Mol Pathol (1972) 0.92
Surface T-antigen expression in simian virus 40-transformed mouse cells: correlation with cell growth rate. Mol Cell Biol (1985) 0.91
Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells. Cell Growth Differ (1991) 0.91
Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology (1996) 0.91
Antigenic analysis of tumors and sera from aimals inoculated with para-adenovirus populations. J Immunol (1966) 0.91
Sequential imaging of indium-111-labeled monoclonal antibody in human mammary tumors hosted in nude mice. J Nucl Med (1984) 0.91
Mouse mammary tumor virus genome expression in chemical carcinogen-induced mammary tumors in low- and high-tumor-incidence mouse strains. Proc Natl Acad Sci U S A (1979) 0.91
Protection of Measles Virus by Sulfate Ions Against Thermal Inactivation. J Bacteriol (1965) 0.90
Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb Haemost (1995) 0.90